| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6335335 | BAUSCH AND LOMB | Prolonged-action eye drop |
Nov, 2018
(5 years ago) | |
| US6645963 | BAUSCH AND LOMB | Prolonged-action eye drop |
Nov, 2018
(5 years ago) | |
Istalol is owned by Bausch And Lomb.
Istalol contains Timolol Maleate.
Istalol has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Istalol are:
- US6335335
- US6645963
Istalol was authorised for market use on 04 June, 2004.
Istalol is available in solution/drops;ophthalmic dosage forms.
The generics of Istalol are possible to be released after 16 November, 2018.
Drugs and Companies using TIMOLOL MALEATE ingredient
Market Authorisation Date: 04 June, 2004
Treatment: NA
Dosage: SOLUTION/DROPS;OPHTHALMIC
How can I launch a generic of ISTALOL before it's drug patent expiration?
More Information on Dosage
ISTALOL family patents
